Part 1/9:
The Highlights of ASCO and Market Developments in Healthcare
The healthcare industry is always evolving, and significant events often provide insight into the future of key players and innovations. One such major event is the American Society of Clinical Oncology (ASCO) conference. In a recent episode of the Industry Focus podcast, Kristine Harjes and Todd Campbell discussed the vital takeaways from this year's ASCO while also delving into specific stock movements, particularly focusing on Immunomedics, CAR-T therapies, AbbVie’s recent acquisition, and Biogen’s disappointing trial results.